CD4 and cancer: Considering the need for robust biomarkers in HNSCC and the contrasting evidence concerning TILs in this cancer group, the aim of this paper was to systematically review and perform a meta-analysis of recent evidence concerning the prognostic significance of CD4+ and CD8+ TIL populations in HNSCC.